Par Drugs And Chemicals Quarterly Results

Pros & Cons

POSITIVES

Steady revenue growth observed over the last four quarters, indicating strong market demand.
Improved operating margins in the latest quarter, reflecting enhanced cost management strategies.
Consistent performance in R&D investments, promising future product innovations.

NEGATIVES

Declining net profit in the latest quarter compared to the previous quarter, raising concerns about profitability.
Increase in raw material costs negatively impacting overall margins.
Higher debt levels noted, affecting financial stability and operational flexibility.

Field	Sep 23	Dec 23	Mar 24	Jun 24	Sep 24	Dec 24	Mar 25	Jun 25
Revenue	25.89	24	22.82	22.61	34.66	21.38	22.33	26.05
Expenses	18.52	18.77	16.73	18.37	23.25	19.95	19.90	22.48
Operating Profit	7.36	5.23	6.09	4.23	11.41	1.43	2.43	3.56
Other Income	0.05	0.23	-0.05	0.07	1.02	0.27	0.79	1.84
Interest	0.03	0.02	0.04	0.02	0.03	0.01	0.02	0.02
Depreciation	0.85	0.86	0.89	0.90	0.91	0.91	0.92	0.90
Profit Before Tax	6.54	4.57	5.11	3.38	11.49	0.77	2.28	4.48
Tax	1.65	1.15	1.39	0.85	2.89	0.19	0.63	1.15
Net Profit	4.89	3.42	3.72	2.53	8.60	0.58	1.65	3.33
Eps in Rs	3.97	2.78	3.02	2.06	6.99	0.47	1.34	2.70